A new pill called Enlicitide may help people who don’t get results from statins. The drug showed big drops in bad cholesterol in early test...

Eli Lilly plans to launch an oral weight loss drug, orforglipron, after Mounjaro's India success. Regulatory submissions are expected soon,...

Novartis introduces a financing scheme with Pine Labs for its cholesterol-lowering drug, Sybrava (inclisiran), in India, aiming to broaden ...

Rising temperatures across various regions of India are driving increased demand for medications aimed at managing chronic conditions. This...

The Mumbai-based drug major said one of its wholly-owned subsidiaries plans to launch a first-in-class oral drug, Bempedoic Acid, in India ...

"With Bemdac we are happy to introduce a first-in-India therapy to address the unmet medical need of people suffering from uncontrolled LDL...

The team led by researchers from the University of Birmingham in the UK found that fenofibrate and its active form fenofibric acid can sign...

The lawsuit widens a complaint of price collusion filed in 2016, which is still pending in US courts after being first investigated in 2014.

While National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices of 20 formulations, it has also capped the ceiling prices of...

The product is used together with diet and exercise to treat obesity (overweight) in people with risk factors such as high blood pressure, ...

The pharmaceutical major has got tentative USFDA approval to sell Niacin oral tablets of strength 500, 750 and 1000 mg in the US market.

Cadila Healthcare on Wednesday said that its new chemical entity (NCE), Lipaglyn , has been approved by the Drug Controller General of Indi...

Cadila Healthcare today said Indian drug regulator has approved its new chemical entity, Lipaglyn to be used for treating a type of diabetes

Pharma major Ranbaxy Laboratories restarts production of generic cholesterol lowering drug Atorvastatin as it looks to resume supplies to U...

The company has received a licence from Daiichi Sankyo and Genzyme that will permit it to launch its generic Colesevelam Hydrochloride prod...

India's top biotechnology firm, Biocon Ltd, is looking at overseas acquisitions for about $10 million to boost its sales globally and gain ...

Glenmark Pharmaceuticals Ltd has received US FDA (United States Food and Drug Administration) approval for an anti-cholesterol drug Pravast...